期刊文献+

Transcription factors,metabolic dysfunction-associated fatty liver disease,and therapeutic implications

原文传递
导出
摘要 Metabolic dysfunction-associated fatty liver disease(MAFLD)encompasses a spectrum of liver diseases ranging from metabolic dysfunction-associated fatty liver to metabolic dysfunction-associated steatohepatitis,which may progress to liver cirrhosis and hepatocellular carcinoma.Several mechanisms,including obesity,insulin resistance,dyslipidemia,inflammation,apoptosis,mitochondrial dysfunction,and reactive oxygen species,have been proposed to underlie the progression of MAFLD.Transcription factors are proteins that specifically bind to DNA sequences to regulate the transcription of target genes.Numerous transcription factors regulate MAFLD by modulating the transcription of genes involved in steatosis,inflammation,apoptosis,and fibrosis.Here,we review the pathological factors associated with MAFLD,with a particular emphasis on the transcription factors that contribute to the progression of MAFLD and their therapeutic implications.
出处 《Genes & Diseases》 2025年第3期137-145,共9页 基因与疾病(英文)
基金 supported by the National Natural Science Foundation of China(No.32271218 to Y.X.).
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部